Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031
about
Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement.Effect of Akimbo versus Raised Arm Positioning on Breast and Cardiopulmonary Dosimetry in Pediatric Hodgkin LymphomaA Comparative Evaluation of Normal Tissue Doses for Patients Receiving Radiation Therapy for Hodgkin Lymphoma on the Childhood Cancer Survivor Study and Recent Children's Oncology Group Trials.Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.Imaging of primary pediatric lymphoma of bone.Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.The evolving role of radiation therapy in pediatric Hodgkin's disease.Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas.Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patients.Management of Hodgkins Lymphoma: ICMR Consensus Document.Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.Proton Therapy for Pediatric Hodgkin Lymphoma.ABVD-Based Therapy for Hodgkin Lymphoma in Children and Adolescents: Lessons Learnt in a Tertiary Care Oncology Center in a Developing Country.Is response-guided therapy being applied in the clinical setting? The hepatitis C example.ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma.Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.Effect of chemotherapy alone with adult chemotherapy regimens on prognosis of children and adolescents with Hodgkin's disease.Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report.Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.Tolerance and effectiveness of nivolumab after pediatric T-cell replete, haploidentical, bone marrow transplantation: A case report.Pharmacotherapeutic Management of Pediatric Lymphoma.Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience.International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy.Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care.Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines.Blastomycosis infection in an adolescent patient with Hodgkin lymphoma.Helical tomotherapy in the radiotherapy treatment of Hodgkin's disease ‐ a feasibility study.
P2860
Q30248284-5786C3AB-E457-486D-BC57-3865FDA81624Q30313537-EBD39EA0-FDC0-43B2-B0BE-835723EAB943Q37124918-6CB266CA-1069-4C6E-B141-B44C928A0926Q37211391-45B51BC8-DD43-4E29-BE5B-E63DBD070157Q38396485-C7B22D3D-AA5E-4F0D-B486-682293E30292Q38775871-2EDB398F-9F91-4474-A195-76B9ADB5EA04Q38797810-8FE55400-566C-445E-9F89-D09E7F744C11Q38817696-A00E99BE-1A4B-401F-A53B-D59C234852EFQ38823537-08D2CBC6-1E51-4653-A946-18EDE7588A6EQ38838220-FAA10F43-DA90-4B11-898B-0020543C26E5Q38843371-9DC8740F-3E7C-4D04-ADFD-943E4B95115DQ39129713-652A521A-182B-4B6E-ACDF-4AA1225CF81DQ39208309-03D9C9EE-32BB-4CDB-BD91-67029BFB8156Q39244757-FD34B2D4-03C7-42F8-ACE8-8B6E1B3FB64AQ39791791-3FF08F89-5CE4-4A7B-B2D9-809C02711930Q40015175-31E70D20-7873-496A-8015-81A3323EF741Q40108102-5A92E6A2-46C2-4B12-BDDD-F6B552F0D385Q40281182-C9DA8575-9840-40C3-8858-D9A00577B542Q40465014-C8E764CC-9C35-4AB2-BA48-9AD33176F91EQ40485032-EC14E620-2ADF-4778-8D0A-04EFC46BBBA1Q40762228-CA6333CC-B75B-48F1-A707-584985BC25FDQ41378943-8C94F764-6C15-4929-9BB8-7403ED0A534DQ45061338-C2D3964B-333A-43A1-B18F-B97F7057B03AQ46379382-972D9D20-BD8E-4488-8FD5-C3BAF1AF4DBAQ47998272-63AC36C6-3BFC-4C07-A87A-84D48231E0A2Q48321203-0E457CD8-234F-4217-ACD1-8BC29F0A1B82Q48548248-316B94A5-EA3C-4FE3-B511-7F4FEE1874D3Q48669191-75BF4D88-883B-48E1-84CB-9958A1140816Q50054777-FFB4CF73-757B-4F97-8905-A5BDCF408D4FQ52722711-F9FBDA89-C235-476E-B2C7-01F3A253627BQ52943519-E99C6FB1-1DDA-4CC6-9817-C7E39F6A65E8Q53708852-D192B542-CB27-4AF2-8DD1-C619BC1C98E1Q54995111-A7AABAAF-D162-41C6-BA3B-64E8DF1BDBC4
P2860
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@ast
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@en
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@nl
type
label
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@ast
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@en
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@nl
prefLabel
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@ast
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@en
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@nl
P2093
P2860
P921
P356
P1476
Dose-intensive response-based ...... Oncology Group Study AHOD0031
@en
P2093
Allen Buxton
Allen R Chen
Cindy L Schwartz
Debra L Friedman
Kathleen McCarten
Louis S Constine
Nathan Kobrinsky
Pedro A De Alarcon
Peter Ehrlich
P2860
P304
P356
10.1200/JCO.2013.52.5410
P407
P577
2014-10-13T00:00:00Z